| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0007114518000946 |
| P698 | PubMed publication ID | 29859544 |
| P50 | author | Robert Hall Michell | Q21165643 |
| P2860 | cites work | Effect of treatment with myo-inositol on semen parameters of patients undergoing an IVF cycle: in vivo study | Q86118420 |
| A pilot study of gestational diabetes mellitus not controlled by diet alone: First-line medical treatment with myoinositol may limit the need for insulin | Q87415878 | ||
| Inositol in preterm infants at risk for or having respiratory distress syndrome | Q24188217 | ||
| Rab10 GTPase regulates ER dynamics and morphology | Q24306806 | ||
| Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and β-Cell Dysfunction | Q26800081 | ||
| Nutritional manipulation for the primary prevention of gestational diabetes mellitus: a meta-analysis of randomised studies | Q26830771 | ||
| The unfolded protein response in retinal vascular diseases: implications and therapeutic potential beyond protein folding | Q26852080 | ||
| Inositol lipids: from an archaeal origin to phosphatidylinositol 3,5-bisphosphate faults in human disease | Q26852772 | ||
| The role of phospholipids in the biological activity and structure of the endoplasmic reticulum | Q27008152 | ||
| Phosphoinositides: tiny lipids with giant impact on cell regulation | Q27012953 | ||
| Toxicant-associated steatohepatitis | Q27687049 | ||
| Signal integration in the endoplasmic reticulum unfolded protein response | Q27860577 | ||
| The phosphoinositide 3-kinase pathway | Q27860738 | ||
| Phosphoinositides in cell regulation and membrane dynamics | Q27861051 | ||
| IRE1 encodes a putative protein kinase containing a membrane-spanning domain and is required for inositol phototrophy in Saccharomyces cerevisiae | Q27935778 | ||
| How to Achieve High-Quality Oocytes? The Key Role of Myo-Inositol and Melatonin | Q28066892 | ||
| Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols | Q28072474 | ||
| Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials | Q28073603 | ||
| Inositol Treatment and ART Outcomes in Women with PCOS | Q28077261 | ||
| Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome | Q28080989 | ||
| Transmembrane protein TMEM170A is a newly discovered regulator of ER and nuclear envelope morphogenesis in human cells | Q28118857 | ||
| Transcriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids: IMPLICATIONS IN RENAL TUBULAR INJURY INDUCED IN OBESITY AND DIABETES | Q28269939 | ||
| Potential role and therapeutic interests of myo-inositol in metabolic diseases | Q28292692 | ||
| Subcellular organelle lipidomics in TLR-4-activated macrophages | Q28397617 | ||
| Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol | Q28506876 | ||
| Lysophosphatidylinositol-acyltransferase-1 (LPIAT1) is required to maintain physiological levels of PtdIns and PtdInsP(2) in the mouse | Q28509988 | ||
| LPIAT1 regulates arachidonic acid content in phosphatidylinositol and is required for cortical lamination in mice | Q28511447 | ||
| Placental endoplasmic reticulum stress in gestational diabetes: the potential for therapeutic intervention with chemical chaperones and antioxidants | Q28830956 | ||
| The unfolded protein response: from stress pathway to homeostatic regulation | Q29547396 | ||
| Circadian integration of metabolism and energetics | Q29619638 | ||
| Defective craniofacial development and brain function in a mouse model for depletion of intracellular inositol synthesis | Q30414460 | ||
| D-Chiro-Inositol Glycans in Insulin Signaling and Insulin Resistance | Q30434215 | ||
| Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner | Q30701525 | ||
| Endoplasmic reticulum stress in nonalcoholic fatty liver disease | Q38027194 | ||
| Transport of glycosylphosphatidylinositol-anchored proteins from the endoplasmic reticulum | Q38079103 | ||
| Inositol pyrophosphates: between signalling and metabolism | Q38110945 | ||
| Enrichment of phosphatidylinositols with specific acyl chains | Q38152126 | ||
| The unfolded protein response in fatty liver disease | Q38162132 | ||
| Metabolism and function of myo-inositol and inositol phospholipids | Q38164564 | ||
| A meta-analysis of inositol for depression and anxiety disorders | Q38178522 | ||
| Lipid landscapes and pipelines in membrane homeostasis | Q38217765 | ||
| Phospholipid synthesis and transport in mammalian cells | Q38253094 | ||
| XBP1 Regulates the Biosynthetic Capacity of the Mammary Gland During Lactation by Controlling Epithelial Expansion and Endoplasmic Reticulum Formation. | Q38295344 | ||
| Form follows function: the importance of endoplasmic reticulum shape | Q38314963 | ||
| Inositol transport proteins | Q38394774 | ||
| Membrane aberrancy and unfolded proteins activate the endoplasmic reticulum stress sensor Ire1 in different ways | Q38394944 | ||
| Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis? | Q38507866 | ||
| Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology--assisted reproduction technology | Q38513382 | ||
| Preventive and Therapeutic Role of Dietary Inositol Supplementation in Periconceptional Period and During Pregnancy: A Summary of Evidences and Future Applications | Q38547308 | ||
| Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS. | Q38610783 | ||
| Glycosylphosphatidylinositol-anchored proteins: Membrane organization and transport | Q38679979 | ||
| Roles of phosphatidylethanolamine and of its several biosynthetic pathways in Saccharomyces cerevisiae | Q38689610 | ||
| Autophagosome formation is initiated at phosphatidylinositol synthase-enriched ER subdomains | Q38703825 | ||
| In-Hospital Breastfeeding Experiences Among Women with Gestational Diabetes | Q38717438 | ||
| Generic membrane-spanning features endow IRE1α with responsiveness to membrane aberrancy | Q38725389 | ||
| Myo-Inositol Supplementation to Prevent Gestational Diabetes Mellitus | Q38742613 | ||
| Advances on the Transfer of Lipids by Lipid Transfer Proteins | Q38745969 | ||
| The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease | Q38836182 | ||
| Inositol's and other nutraceuticals' synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives | Q38901819 | ||
| Inositol as putative integrative treatment for PCOS. | Q38975362 | ||
| Biogenesis of secretory organelles during B cell differentiation | Q39138911 | ||
| Endoplasmic Reticulum (ER) Stress and Endocrine Disorders. | Q39139204 | ||
| Biochemistry of the glycosyl-phosphatidylinositol membrane protein anchors | Q39483162 | ||
| Generation by Insulin of a Chemical Mediator That Controls Protein Phosphorylation and Dephosphorylation | Q40270881 | ||
| Proliferation and Morphogenesis of the Endoplasmic Reticulum Driven by the Membrane Domain of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Plant Cells. | Q40898537 | ||
| Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial | Q41515750 | ||
| Diphosphoinositide and triphosphoinositide in animal tissues. Extraction, estimation and changes post mortem | Q41849792 | ||
| The renal excretion of inositol in normal and diabetic human beings | Q41859806 | ||
| Studies on Inositol: The Synthesis of Inositol in the Animal Body | Q42160697 | ||
| Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality | Q42521935 | ||
| A novel biosynthetic pathway of archaetidyl-myo-inositol via archaetidyl-myo-inositol phosphate from CDP-archaeol and D-glucose 6-phosphate in methanoarchaeon Methanothermobacter thermautotrophicus cells. | Q42660937 | ||
| Mammalian diseases of phosphatidylinositol transfer proteins and their homologs | Q42736093 | ||
| Synthetic inositol phosphoglycans related to GPI lack insulin-mimetic activity | Q42820793 | ||
| Coordinate regulation of phospholipid biosynthesis and secretory pathway gene expression in XBP-1(S)-induced endoplasmic reticulum biogenesis. | Q42832143 | ||
| Membrane dynamics and organelle biogenesis-lipid pipelines and vesicular carriers | Q43140108 | ||
| Circadian clock-coordinated 12 Hr period rhythmic activation of the IRE1alpha pathway controls lipid metabolism in mouse liver | Q43194435 | ||
| Spatial regulation of phospholipid synthesis within the nuclear envelope domain of the endoplasmic reticulum | Q43206188 | ||
| Mice lacking phosphatidylinositol transfer protein-alpha exhibit spinocerebellar degeneration, intestinal and hepatic steatosis, and hypoglycemia | Q44467163 | ||
| Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study | Q45146029 | ||
| D-chiro-inositol and pinitol extend the life span of Drosophila melanogaster | Q45750529 | ||
| Regulated transcription of the Saccharomyces cerevisiae phosphatidylinositol biosynthetic gene, PIS1, yields pleiotropic effects on phospholipid synthesis. | Q46003929 | ||
| Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial | Q46085298 | ||
| Extraction of polyphosphoinositides with neutral and acidified solvents. A comparison of guinea-pig brain and liver, and measurements of rat liver inositol compounds which are resistant to extraction. | Q46185909 | ||
| Metabolic syndrome enhances endoplasmic reticulum, oxidative stress and leukocyte-endothelium interactions in PCOS. | Q46363907 | ||
| In vitro effect of myo-inositol on sperm motility in normal and oligoasthenospermia patients undergoing in vitro fertilization | Q46451605 | ||
| Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome. | Q46477334 | ||
| Nutritional and Acquired Deficiencies in Inositol Bioavailability. Correlations with Metabolic Disorders | Q47162682 | ||
| Genetics and epigenetics of NAFLD and NASH: Clinical impact | Q47623021 | ||
| The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial. | Q48096154 | ||
| The pathologies associated with functional titration of phosphatidylinositol transfer protein alpha activity in mice | Q48156385 | ||
| Does myo-inositol effect on PCOS follicles involve cytoskeleton regulation? | Q48551570 | ||
| Myoinositol improves sperm parameters and serum reproductive hormones in patients with idiopathic infertility: a prospective double-blind randomized placebo-controlled study. | Q48581607 | ||
| Hyperinsulinemia Alters Myoinositol to d-chiroinositol Ratio in the Follicular Fluid of Patients With PCOS. | Q48608973 | ||
| Abnormalities in myo-inositol metabolism associated with type 2 diabetes in mice fed a high-fat diet: benefits of a dietary myo-inositol supplementation | Q48801302 | ||
| PKB/Akt and MAPK/ERK phosphorylation is highly induced by inositols: Novel potential insights in endothelial dysfunction in preeclampsia | Q49886993 | ||
| Activation of the Unfolded Protein Response by Lipid Bilayer Stress. | Q50540191 | ||
| Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. | Q50785948 | ||
| One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome. | Q50791267 | ||
| A Eukaryotic Sensor for Membrane Lipid Saturation. | Q50795723 | ||
| The effect of combined inositol supplementation on maternal metabolic profile in pregnancies complicated by metabolic syndrome and obesity. | Q50891727 | ||
| The active site of yeast phosphatidylinositol synthase Pis1 is facing the cytosol. | Q50958328 | ||
| Increased spatiotemporal resolution reveals highly dynamic dense tubular matrices in the peripheral ER. | Q51358415 | ||
| Inositol prevents folate-resistant neural tube defects in the mouse. | Q52197912 | ||
| Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS). | Q52841821 | ||
| A phytotherapic approach to reduce sperm DNA fragmentation in patients with male infertility. | Q53536737 | ||
| Inositol, neural tube closure and the prevention of neural tube defects. | Q54229439 | ||
| The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans. | Q54539620 | ||
| Changing phosphoinositides "on the fly": how trafficking vesicles avoid an identity crisis. | Q54724417 | ||
| Chronic treatment with d-chiro-inositol prevents autonomic and somatic neuropathy in STZ-induced diabetic mice | Q54966680 | ||
| Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance | Q61855582 | ||
| Diurnal Rhythm in Endoplasmic Reticulum of Rat Liver: Electron Microscopic Study | Q67273868 | ||
| Inositol deficiency increases the susceptibility to neural tube defects of genetically predisposed (curly tail) mouse embryos in vitro | Q68178132 | ||
| Changes in the levels of inositol lipids and phosphates during the differentiation of HL60 promyelocytic cells towards neutrophils or monocytes | Q68327035 | ||
| myo-inositol action on gerbil intestine: alterations in alkaline phosphatase activity upon phosphatidylinositol depletion and repletion in vivo | Q69052378 | ||
| myo-Inositol action on gerbil intestine. Association of phosphatidylinositol metabolism with lipid clearance | Q72656143 | ||
| Null mutation in IRE1 gene inhibits overproduction of microsomal cytochrome P450Alk1 (CYP 52A3) and proliferation of the endoplasmic reticulum in Saccharomyces cerevisiae | Q74525993 | ||
| The versatility of inositol phosphates as cellular signals | Q77631236 | ||
| D-pinitol regulates Th1/Th2 balance via suppressing Th2 immune response in ovalbumin-induced asthma | Q79437940 | ||
| Phospholipid biosynthesis program underlying membrane expansion during B-lymphocyte differentiation | Q79527401 | ||
| Renal depletion of myo-inositol is associated with its increased degradation in animal models of metabolic disease | Q86010454 | ||
| Formation of stacked ER cisternae by low affinity protein interactions | Q31018281 | ||
| Molecular species of phosphatidylinositol-cycle intermediates in the endoplasmic reticulum and plasma membrane | Q33587724 | ||
| Hepatic rhythmicity of endoplasmic reticulum stress is disrupted in perinatal and adult mice models of high-fat diet-induced obesity | Q33588845 | ||
| Endoplasmic Reticulum Stress and Homeostasis in Reproductive Physiology and Pathology | Q33624611 | ||
| Insulin-mimicking bioactivities of acylated inositol glycans in several mouse models of diabetes with or without obesity | Q33817243 | ||
| Lack of de novo phosphatidylinositol synthesis leads to endoplasmic reticulum stress and hepatic steatosis in cdipt-deficient zebrafish | Q33871146 | ||
| Strategies for acquiring the phospholipid metabolite inositol in pathogenic bacteria, fungi and protozoa: making it and taking it. | Q33928824 | ||
| Urinary chiro- and myo-inositol levels as a biological marker for type 2 diabetes mellitus. | Q34033525 | ||
| Pathogenesis of diabetes-induced congenital malformations | Q34091873 | ||
| Myo-inositol content of common foods: development of a high-myo-inositol diet | Q34286856 | ||
| Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients | Q34546109 | ||
| Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials | Q34557177 | ||
| Involvement of inositol in reproduction | Q34573998 | ||
| Distinct properties of the two isoforms of CDP-diacylglycerol synthase | Q34631154 | ||
| Inositol derivatives: evolution and functions | Q34740418 | ||
| Selective activation of the transcription factor ATF6 mediates endoplasmic reticulum proliferation triggered by a membrane protein | Q34977917 | ||
| Intersection of the unfolded protein response and hepatic lipid metabolism | Q34985745 | ||
| CDP-diacylglycerol synthetase coordinates cell growth and fat storage through phosphatidylinositol metabolism and the insulin pathway | Q35113029 | ||
| Polyphosphoinositide binding domains: Key to inositol lipid biology. | Q35236004 | ||
| The renal excretion of inositol by normal and diabetic rats | Q35268898 | ||
| Epithelial Xbp1 is required for cellular proliferation and differentiation during mammary gland development | Q35288559 | ||
| Endoplasmic reticulum stress is increased in adipose tissue of women with gestational diabetes | Q35306325 | ||
| A novel method for the purification of inositol phosphates from biological samples reveals that no phytate is present in human plasma or urine | Q35318869 | ||
| Diversification and evolution of L‐myo‐inositol 1‐phosphate synthase1 | Q35556134 | ||
| CDP-diacylglycerol phospholipid synthesis in detergent-soluble, non-raft, membrane microdomains of the endoplasmic reticulum | Q35561957 | ||
| A highly dynamic ER-derived phosphatidylinositol-synthesizing organelle supplies phosphoinositides to cellular membranes | Q35607232 | ||
| Trypanosoma brucei Bloodstream Forms Depend upon Uptake of myo-Inositol for Golgi Complex Phosphatidylinositol Synthesis and Normal Cell Growth | Q35675245 | ||
| Saturated phosphatidic acids mediate saturated fatty acid-induced vascular calcification and lipotoxicity | Q35827400 | ||
| Endoplasmic reticulum stress in liver disease | Q36031838 | ||
| Dominant negative FADD dissipates the proapoptotic signalosome of the unfolded protein response in diabetic embryopathy. | Q36297515 | ||
| myo-Inositol Oxygenase Overexpression Accentuates Generation of Reactive Oxygen Species and Exacerbates Cellular Injury following High Glucose Ambience: A NEW MECHANISM RELEVANT TO THE PATHOGENESIS OF DIABETIC NEPHROPATHY | Q36674645 | ||
| Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains | Q36712468 | ||
| Inositol for the prevention of neural tube defects: a pilot randomised controlled trial | Q36779043 | ||
| The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent | Q36833028 | ||
| Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease | Q36880313 | ||
| Inositol lipid regulation of lipid transfer in specialized membrane domains. | Q36881382 | ||
| Treating Woman with Myo-Inositol Vaginal Suppositories Improves Partner's Sperm Motility and Fertility | Q37043826 | ||
| A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women. | Q37132257 | ||
| d- chiro-Inositol is absorbed but not synthesised in rodents | Q37140717 | ||
| Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trial | Q37152708 | ||
| ATF6alpha induces XBP1-independent expansion of the endoplasmic reticulum | Q37186859 | ||
| Endoplasmic Reticulum Stress May Play a Pivotal Role in Lipid Metabolic Disorders in a Novel Mouse Model of Subclinical Hypothyroidism | Q37189088 | ||
| Myo-Inositol in the Treatment of Teenagers Affected by PCOS. | Q37222857 | ||
| MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C. | Q37264708 | ||
| Diphosphoinositol polyphosphates: metabolic messengers? | Q37268113 | ||
| In Vitro Antioxidant Treatment of Semen Samples in Assisted Reproductive Technology: Effects of Myo-Inositol on Nemaspermic Parameters | Q37273756 | ||
| Membrane phospholipid synthesis and endoplasmic reticulum function | Q37308781 | ||
| Effect of Myoinositol and Antioxidants on Sperm Quality in Men with Metabolic Syndrome | Q37323667 | ||
| Myoinositol Improves Embryo Development in PCOS Patients Undergoing ICSI | Q37335197 | ||
| Mutations in MBOAT7, Encoding Lysophosphatidylinositol Acyltransferase I, Lead to Intellectual Disability Accompanied by Epilepsy and Autistic Features | Q37342009 | ||
| The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes. | Q37363630 | ||
| Membrane expansion alleviates endoplasmic reticulum stress independently of the unfolded protein response. | Q37425584 | ||
| Dysregulated phosphatidylinositol signaling promotes endoplasmic-reticulum-stress-mediated intestinal mucosal injury and inflammation in zebrafish | Q37438514 | ||
| Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus: A Prospective Cohort Study | Q37540302 | ||
| Spatial control of phospholipid flux restricts endoplasmic reticulum sheet formation to allow nuclear envelope breakdown | Q37541029 | ||
| Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants | Q37544118 | ||
| Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis. | Q37602052 | ||
| Contribution of myo-inositol to reproduction | Q37607696 | ||
| Signalling pathways in the unfolded protein response: development from yeast to mammals | Q37622607 | ||
| The metabolic syndrome: common origins of a multifactorial disorder | Q37628332 | ||
| Treatment with Myo-Inositol and Selenium Ensures Euthyroidism in Patients with Autoimmune Thyroiditis. | Q37673038 | ||
| The response to inositol: regulation of glycerolipid metabolism and stress response signaling in yeast | Q37692823 | ||
| Inositol and In Vitro Fertilization with Embryo Transfer | Q37699892 | ||
| Inositol phosphate synthesis and the nuclear processes they affect | Q37723028 | ||
| Diabetes as a disease of endoplasmic reticulum stress | Q37797970 | ||
| P433 | issue | 3 | |
| P921 | main subject | endoplasmic reticulum | Q79927 |
| P304 | page(s) | 1-16 | |
| P577 | publication date | 2018-06-03 | |
| P1433 | published in | British Journal of Nutrition | Q4970206 |
| P1476 | title | Do inositol supplements enhance phosphatidylinositol supply and thus support endoplasmic reticulum function? | |
| P478 | volume | 120 |
| Q89967641 | CDP-Diacylglycerol Synthases (CDS): Gateway to Phosphatidylinositol and Cardiolipin Synthesis |
| Q97524388 | Inositols and metabolic disorders: From farm to bedside |
| Q90647042 | Probing the subcellular distribution of phosphatidylinositol reveals a surprising lack at the plasma membrane |
| Q99233914 | The precursor of PI(3,4,5)P3 alleviates aging by activating daf-18(Pten) and independent of daf-16 |
| Q90637928 | Unfolded protein-independent IRE1 activation contributes to multifaceted developmental processes in Arabidopsis |
Search more.